Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Abrdn Global Premier Properties Fund | AWP | Jan 16, 2025 | 3.95 | +1.80 |
Abrdn Healthcare Opportunities Fund Shares Of Beneficial Int | THQ | Jan 16, 2025 | 19.92 | +1.27 |
Abrdn Life Sciences Investors Shares Of Beneficial Interest | HQL | Jan 16, 2025 | 13.53 | +0.30 |
Abrdn National Municipal Income Fund | VFL | Jan 16, 2025 | 10.35 | +0.39 |
Abrdn Total Dynamic Dividend Fund | AOD | Jan 16, 2025 | 8.67 | +0.58 |
Abrdn World Healthcare Fund Shares Of Beneficial Interest | THW | Jan 16, 2025 | 11.61 | +0.87 |
Absci | ABSI | Jan 16, 2025 | 2.80 | -2.10 |
ABVC Biopharma | ABVC | Jan 16, 2025 | 0.55 | +1.12 |
Ac Immune SA | ACIU | Jan 16, 2025 | 2.64 | -1.49 |
Acacia Research | ACTG | Jan 16, 2025 | 4.37 | 0.00 |
Academy Sports and Outdoors | ASO | Jan 16, 2025 | 52.46 | +0.19 |
Acadia Healthcare | ACHC | Jan 16, 2025 | 41.95 | -2.53 |
Acadia Pharmaceuticals | ACAD | Jan 16, 2025 | 17.52 | +0.06 |
Acadia Realty Trust | AKR | Jan 16, 2025 | 22.90 | +1.96 |
Acadian Asset Management | AAMI | Jan 16, 2025 | 25.15 | 0.00 |
Accel Entertainment | ACEL | Jan 16, 2025 | 10.63 | -0.09 |
Accelerate Diagnostics | AXDX | Jan 16, 2025 | 1.12 | -0.88 |
Accenture A | ACN | Jan 16, 2025 | 350.56 | +0.24 |
Acco Brands | ACCO | Jan 16, 2025 | 5.21 | +0.58 |
Accolade | ACCD | Jan 16, 2025 | 6.86 | +0.07 |
Accuray | ARAY | Jan 16, 2025 | 2.30 | 0.00 |
Acelyrin | SLRN | Jan 16, 2025 | 1.99 | -1.49 |
Achieve Life Sciences | ACHV | Jan 16, 2025 | 3.07 | -6.40 |
Achilles Therapeutics ADR | ACHL | Jan 16, 2025 | 1.15 | -0.86 |
ACI Worldwide | ACIW | Jan 16, 2025 | 54.34 | +1.61 |
Aclarion | ACON | Jan 16, 2025 | 0.04 | +5.88 |
Aclaris Therapeutics | ACRS | Jan 16, 2025 | 2.51 | 0.00 |
ACM Research A | ACMR | Jan 16, 2025 | 17.68 | -1.17 |
Acme United | ACU | Jan 16, 2025 | 36.58 | +0.22 |
ACNB | ACNB | Jan 16, 2025 | 38.69 | -0.10 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.